Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for
04:11pm, Monday, 21'st Feb 2022
Aurinia (AUPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Check Out What Whales Are Doing With AUPH
08:33pm, Wednesday, 16'th Feb 2022 Benzinga
A whale with a lot of money to spend has taken a noticeably bullish stance on Aurinia Pharmaceuticals . Looking at options history for Aurinia Pharmaceuticals (NASDAQ: AUPH ) we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 33% with bearish. From the overall spotted trades, 2 are puts, for a total amount of $81,447 and 10, calls, for a total amount of $474,702. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price … Full story available on Benzinga.com
Aurinia Pharma gains after CEO comments on sales outlook
04:35pm, Wednesday, 16'th Feb 2022 Seeking Alpha
Aurinia Pharmaceuticals <> is trading higher after its Chief Executive Officer Peter Greenleaf hinted at strong sales for the company as the management prepares to release…
What to Expect From Biogen's $2.3 Billion Shopping Spree
11:30am, Saturday, 12'th Feb 2022 The Motley Fool
The company has several interesting companies on its short list.
A Subscriber Wants to Know If Aurinia Pharmaceuticals'' Charts Have Improved
02:33pm, Thursday, 10'th Feb 2022 The Street RealMoney
Prices look like they can bounce further to the upside in the short-run but the longer-term picture is problematic….AUPH
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
09:17pm, Wednesday, 09'th Feb 2022 Kwhen FinanceAurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
04:17pm, Wednesday, 09'th Feb 2022
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that it will release its fourth quarter and year end 2021 financial results
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
07:05am, Thursday, 03'rd Feb 2022
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that the company will deliver a corporate presentation at the 11th Annual L
6 Top Biotech Ideas For 2022
09:28am, Thursday, 20'th Jan 2022
6 Top Biotech Ideas For 2022
Aurinia Pharmaceuticals reverses decline after report on potential M&A interest
07:49pm, Thursday, 13'th Jan 2022 Seeking Alpha
Aurinia Pharmaceuticals (AUPH) reversed an earlier decline and is now up 3.4% after a report indicated Biogen (BIIB) could potentially look to target the company.Aurinia (AUPH) was
My 3 Top Biopharma Stock Picks for 2022
03:30pm, Sunday, 09'th Jan 2022 The Motley Fool
These three stocks are poised for a major breakout in 2022.
My 3 Top Biopharma Stock Picks for 2022
10:30am, Sunday, 09'th Jan 2022
These three stocks are poised for a major breakout in 2022.
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
04:17pm, Tuesday, 04'th Jan 2022
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtua
Aurinia Pharmaceuticals Inc. (AUPH) Is Waiting On The Launchpad To Make A Splash.
03:00pm, Thursday, 23'rd Dec 2021 Stocks Register
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) concluded the trading at $22.69 on Wednesday, December 22 with a rise of 0.62% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $22.55 and 5Y monthly beta was reading 0.66 with its price kept floating in the Aurinia Pharmaceuticals Inc. (AUPH) Is Waiting On The Launchpad To Make A Splash. Read More »
